| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/11/2007 | EP1806353A1 Antisense modulation of novel anti-apoptotic BCL-2-related proteins |
| 07/11/2007 | EP1806349A1 Antitumoral analogs |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806141A1 Par-2 antagonists |
| 07/11/2007 | EP1806138A1 Anti-tumor agents comprising boroproline compounds |
| 07/11/2007 | EP1806132A1 STAT3 PHOSPHORYLATION INHIBITOR AND Notch1 EXPRESSION INHIBITOR |
| 07/11/2007 | EP1805222A1 Antibodies directed to the mammalian eag1 ion channel protein |
| 07/11/2007 | EP1805220A1 Method for treating tumors using anti-osteopontin antibodies |
| 07/11/2007 | EP1805219A1 Angiopoietin-2 specific binding agents |
| 07/11/2007 | EP1805214A2 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/11/2007 | EP1805175A1 Novel azaindole thiazolinones as anti-cancer agents |
| 07/11/2007 | EP1805174A1 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 07/11/2007 | EP1805161A2 Isomigrastatin analogs in the treatment of cancer |
| 07/11/2007 | EP1805160A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 07/11/2007 | EP1805154A2 Pharmaceutical compositions |
| 07/11/2007 | EP1804838A2 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 07/11/2007 | EP1804830A2 Cancer-testis antigens |
| 07/11/2007 | EP1804828A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 07/11/2007 | EP1804827A1 Methods for treating cancer |
| 07/11/2007 | EP1804809A2 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor |
| 07/11/2007 | EP1804803A2 Compounds and compositions as hedgehog pathway modulators |
| 07/11/2007 | EP1804802A2 Combination comprising zd6474 and an imatinib |
| 07/11/2007 | EP1804800A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-ý4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 07/11/2007 | EP1804786A2 Substituted n-aryl-9-oxo-9h-fluorene-1-carboxamides and analogs as activators of caspases and inducers of apoptosis |
| 07/11/2007 | EP1804779A1 Use of an mtor inhibitor in treatment of uterine leiomyoma |
| 07/11/2007 | EP1596874B1 Method for treating liver cancer by intrahepatic administration of nemorubicin |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1395829B1 Cancer associated protein |
| 07/11/2007 | EP1366021B1 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 07/11/2007 | EP1309597B1 Polymorphs of an epothilone analog |
| 07/11/2007 | EP1307198A4 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP1153122B1 Maturation of dendritic cells with immune response modifying compounds |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | EP0979246B1 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/11/2007 | CN1997657A Therapeutic heparins and their binding to interleukins 4 and 5, and PECAM-1 |
| 07/11/2007 | CN1997655A Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 07/11/2007 | CN1997632A Geldanamycin and derivatives inhibit cancer invasion and identify novel targets |
| 07/11/2007 | CN1997629A Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR's) |
| 07/11/2007 | CN1997403A Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| 07/11/2007 | CN1997402A Cytotoxic compounds and conjugates |
| 07/11/2007 | CN1997400A Conjugated psychotropic drugs and uses thereof |
| 07/11/2007 | CN1997396A Combination therapy of AZD2171 and taxane |
| 07/11/2007 | CN1997394A Compositions and methods comprising an EGFL7 antagonist for modulating vascular development |
| 07/11/2007 | CN1997388A Mucinous glycoprotein (MUC-1) vaccine |
| 07/11/2007 | CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/11/2007 | CN1997365A Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| 07/11/2007 | CN1995356A Fusion gene vector construction and expression as well as uses |
| 07/11/2007 | CN1995065A Fusion protein for suppressing PTTG expression and its coding gene and uses |
| 07/11/2007 | CN1995064A Long-lasting recombinant human red blood cell growth factor fusion protein and method |
| 07/11/2007 | CN1995061A Cyclamin I and its preparation method and pharmaceutical composition |
| 07/11/2007 | CN1995060A Cyclamin A and its preparation method and use thereof |
| 07/11/2007 | CN1995056A Curcumenol glucoside compound and its preparation method and uses |
| 07/11/2007 | CN1995055A Carbohydrate derivative, platinum complex with antitumour activity and its preparation method |
| 07/11/2007 | CN1995041A Pyridazineindole derivative and its use |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1995029A Cnidium lactone derivant and preparation method and application thereof |
| 07/11/2007 | CN1995028A Chinese sumac lactone A , preparation method and its use in pharmacy |
| 07/11/2007 | CN1994998A 4-methyl cyclopentadecanone and its uses |
| 07/11/2007 | CN1994463A Preparation and use of immune formulation |
| 07/11/2007 | CN1994455A Enteric coated Chinese medicinal capsule for treating cancer and preparation method thereof |
| 07/11/2007 | CN1994391A Application of schisandra fruit in preparation of tyrosine-inhibiting medicine |
| 07/11/2007 | CN1994379A Method for preparing total saponin of radde anemone rhizome |
| 07/11/2007 | CN1994365A An anti-tumor pharmaceutical composition |
| 07/11/2007 | CN1994353A A superfine powdered Chinese medicinal composition and preparation method thereof |
| 07/11/2007 | CN1994341A Preparation process of total phenolic acids of water cress and pharmaceutical formulation using the ingredient as bulk drug and use thereof for treating liver disease |
| 07/11/2007 | CN1994335A Preparation method of detoxification tablet with toad and poria |
| 07/11/2007 | CN1994318A Preparation method and anti-tumor medicine containing nano scheelite |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994295A Enteric-coated pharmaceutical composition of mycophenolic acid salt |
| 07/11/2007 | CN1994293A Application of oridonin in medicine preparation |
| 07/11/2007 | CN1994291A Target-oriented sustained-release microsphere containing paclitaxel and albumin and preparation process thereof |
| 07/11/2007 | CN1994289A Application of dibenzocyclootadiene lignans in preparation of tyrosine-inhibiting medicine |
| 07/11/2007 | CN1994287A 抗癌组合 Anticancer combination |
| 07/11/2007 | CN1994279A Preparation process of irinotecan hydrochloride liposome for injection |
| 07/11/2007 | CN1994277A Solid preparation of salvianolic acid A of red sage root and preparation process thereof |
| 07/11/2007 | CN1994150A Yew beverage |
| 07/11/2007 | CN1994126A Preparation method of functional food for relieving cancer and AIDS |
| 07/11/2007 | CN1994119A Fig active element and preparation process thereof |
| 07/11/2007 | CN1325933C Radioactive emission detector with position tracking system and application in therapeutical system and treatment process |
| 07/11/2007 | CN1325918C Materials and methods for examining and treating nasopharyngeal carcinoma |
| 07/11/2007 | CN1325651C High-efficiency expression and application of human recombinant interferon B |
| 07/11/2007 | CN1325647C Selectively replicating viral vectors |
| 07/11/2007 | CN1325514C Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method |
| 07/11/2007 | CN1325507C 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325497C Pharmaceutically active isoindoline derivs. |
| 07/11/2007 | CN1325494C 3-substituted nalidixic acid analog compound and its preparation method and uses in pharmacy |
| 07/11/2007 | CN1325491C Novel crystals |
| 07/11/2007 | CN1325487C Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents |
| 07/11/2007 | CN1325482C Biscyanophenylmethyl-triazole for use in prevention of breast cancer |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325476C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 07/11/2007 | CN1325117C 联合疫苗组合物 Combined vaccine composition |